Screening for obstructive sleep apnea in type 2 diabetes patients - questionnaires are not good enough
2016
Abstract
The shorter life expectancy of patients with type 2 diabetes caused by cardiovascular and cerebrovascular diseases compels clinicians to make a systematic effort to address traditional cardiovascular risk factors, such as dyslipidemia, hypertension, hyperglycemia, obesity, and smoking. However, another major cardiovascular risk factor substantially influencing the quality and length of life - obstructive sleep apnea syndrome (OSA) - is frequently overlooked.
Numerous epidemiological studies have proved that untreated OSA represents an independent risk factor significantly increasing all cause as well as cardiovascular, cerebrovascular, and cancer mortality.